GEHC logo

GE HealthCare Technologies Inc. (GEHC)

$79.22

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on GEHC

Market cap

$36.10B

EPS

4.55

P/E ratio

17.3

Price to sales

1.75

Dividend yield

0.177%

Beta

1.230623

Price on GEHC

Previous close

$79.08

Today's open

$79.41

Day's range

$79.13 - $80.59

52 week range

$57.65 - $94.80

Profile about GEHC

CEO

Peter J. Arduini

Employees

54000

Headquarters

Chicago, IL

Exchange

Nasdaq Global Select

Shares outstanding

455749767

Issue type

Common Stock

GEHC industries and sectors

Healthcare

Medical Diagnostics & Screening

News on GEHC

GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency

GE HealthCare launches ReadyFix in the United States, a remote fleet management tool for MAC VU360 ECGs to boost device uptime and efficiency across hospitals.

news source

Zacks Investment Research • 18 hours ago

news preview

GEHC Strengthens AI Fetal Ultrasound via Diagnoly Collaboration

GE HealthCare and Diagnoly unite to embed AI fetal screening in Voluson ultrasounds, expanding FDA-cleared tools to drive software-led growth and differentiation.

news source

Zacks Investment Research • Feb 9, 2026

news preview

GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the United States launch of ReadyFix™, a remote fleet management solution designed to help healthcare systems support device uptime. ReadyFix will seamlessly integrate with GE HealthCare's MAC VU360™ resting ECG workstations, which are designed to deliver high-quality ECG readings that help clinicians make faster, more confident cardiac care decisions. When paired with ReadyFix, healthcare systems can leverage real-time** da.

news source

Business Wire • Feb 9, 2026

news preview

GE HealthCare Technologies Pops, And The Upside Isn't Over Yet

GE HealthCare Technologies delivered strong Q4 2025 results, with revenue and adjusted EPS exceeding analyst expectations and robust segmental growth. GEHC remains a 'buy' as shares are attractively valued relative to peers, despite recent outperformance and an absolute valuation near fair value. Key growth drivers include the Imaging and Pharmaceutical Diagnostics segments, innovation in cloud-first imaging, and strategic acquisitions like Intelerad.

news source

Seeking Alpha • Feb 5, 2026

news preview

GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices

GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust demand for its diagnostic and imaging devices.

news source

Reuters • Feb 4, 2026

news preview

GE HealthCare Beats Earnings But Margin Pressure, Tariff Costs Could Weigh On Profitability

GE HealthCare (NASDAQ: GEHC) on Wednesday reported adjusted earnings of $1.44 per share, beating the consensus of $1.40.

news source

Benzinga • Feb 4, 2026

news preview

GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic environment.

news source

WSJ • Feb 4, 2026

news preview

GE HealthCare Stock Rises. Why Earnings Were a Relief.

Wednesday, GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for earnings per share of $1.40 from sales of $5.6 billion.

news source

Barrons • Feb 4, 2026

news preview

GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript

GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • Feb 4, 2026

news preview

GE HealthCare reports fourth quarter and full year 2025 financial results

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2025. GE HealthCare President and CEO Peter Arduini said, “In our third year as a public company, we've made great strides executing our strategy focused on precision care, growth acceleration, and business optimization. We delivered a strong quarter and year with growth in Pharmaceutical Diagnostics, Imaging, and Advanced Visualization Solutions. This.

news source

Business Wire • Feb 4, 2026

news preview

¹ Disclosures

Get started with M1

Invest in GE HealthCare Technologies Inc.

Open an M1 investment account to buy and sell GE HealthCare Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in GEHC on M1